Sai Life Sciences surges 8% after strong quarter, profit jumps 86% YoYSai Life Sciences surges 8% after strong quarter, profit jumps 86% YoY

Introduction

Leading pharmaceutical services firm reported strong Q3FY26 performance with higher revenue, EBITDA and profit, supported by growth across contract research and manufacturing services segments globally.

Also Read: JSW Cement rallies 10% after strong turnaround as Q3 profit hits ₹130.62 Cr

Share price movement of Sai Life Sciences

On February 6, 2026, Sai Life Sciences Ltd opened at ₹850.45, up 4.84% from its previous close of ₹811.20. The stock hit a high of ₹877.25 (8.14%) and a low of ₹826.80. By 11:43 AM, it traded at ₹851.80, up 5.00%, with a market capitalisation of ₹17,992.64 crore.

Sai Life Sciences Q3 Results

Sai Life Sciences Limited reported profit after tax of ₹100 crore in Q3FY26, compared with ₹54 crore in Q3FY25, recording an 86% year on year increase during the quarter.

Revenue from operations stood at ₹556 crore in Q3FY26, rising from ₹440 crore in Q3FY25, reflecting a 27% increase driven by CRO and CDMO services growth.

EBITDA for Sai Life Sciences Limited reached ₹191 crore in Q3FY26, compared to ₹124 crore in Q3FY25, marking a 54% year on year increase during the quarter.

Stock performance of Sai Life Sciences for Period of 1 week, 6 months, and 1 year

Sai Life Sciences Ltd declined 2.91% over the past week, slipped 2.06% over the past six months, and gained 9.46% over the past one year.

Also Read: Waaree Energies arm bags 150 MW solar module order in the US; check details

Shareholding pattern of Sai Life Sciences

Particulars	Dec 2025	Sep 2025	Jun 2025
Promoter	34.70%	34.90%	35.20%
FII	21.40%	22.50%	14.60%
DII	31.40%	29.90%	21.60%
Public	12.50%	12.70%	28.60%

About Sai Life Sciences

Sai Life Sciences Limited (NSE: SAILIFE) is an Indian CRDMO providing integrated research, development and manufacturing services to global pharmaceutical and biotech companies from India.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs